Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02066948 · ClinicalTrials.gov registry record · NA
Meal Patterning on Weight Loss With Changes to Body Comp, Muscle and Metabolic Health
A NA study, sponsored by Purdue University.
- Completed
- Registry status
- NA
- Development phase
- 41
- Enrollment target
NCT02066948: Completed NA study, sponsored by Purdue University.
NCT02066948 is a NA study that has completed, run by Purdue University. The registered enrollment target is 41 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02066948, a NA study, has completed, sponsored by Purdue University.
- COMPLETED
- Registry status
- NA
- Development phase
- 41 participants
- Enrollment target
Study Summary
About two-thirds of adults in the United States are overweight or obese with likely adverse health consequences. A Moderate weight loss by dieting and exercise is recommended to improve health. We are interested to know whether eating dietary protein at different times of the day influences changes in body composition, muscle and indices of health. The purpose of this study is to examine the effects of within-day patterning of dietary protein intake (even vs. skewed) on energy-restriction and resistance training-induced changes in body composition, muscle size, appetite, and clinical health (including blood glucose and blood pressure).
Primary Outcome
Fasting-state body weight and waist and hip circumferences will be measured. Body composition (fat mass, lean body mass, and bone mass) will also be determined using Dual Energy X-ray Absorptiometry (DXA, GE Healthcare LUNAR iDXA™ with EnCORE software version 5.60, Madison, WI).
Interventions
- OTHER wt loss
- OTHER Meal Pattern
- OTHER meal pattern
- DIETARY_SUPPLEMENT even
- DIETARY_SUPPLEMENT skew
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 41 participants |
| Start Date | 2014-01 |
| Est. Completion | 2015-11 |
| Phase | NA |
What the finished NCT02066948 record still lists
NCT02066948 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 41 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower).
The record links to 0 conditions, and to 5 interventions - of which wt loss is the first listed.
NCT02066948 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02066948 about?
NCT02066948 is a clinical study titled "Meal Patterning on Weight Loss With Changes to Body Comp, Muscle and Metabolic Health". About two-thirds of adults in the United States are overweight or obese with likely adverse health consequences. A Moderate weight loss by dieting and exercise is recommended to improve health. We are interested to know whether eating dietary protein at different times of the day influences changes ...
What is the current status of trial NCT02066948?
This trial is currently completed. It is a NA study. The enrollment target is 41 participants. The study started on 2014-01. Estimated completion is 2015-11.
What interventions are being tested in trial NCT02066948?
The interventions under investigation include: wt loss (OTHER), Meal Pattern (OTHER), meal pattern (OTHER), even (DIETARY_SUPPLEMENT), skew (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT02066948?
This trial is sponsored by Purdue University, which has 141 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02066948's enrollment target sits among peer trials
41 1446th of 2000 higher than 554 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03449238 · 41 participants · Phase 1
Pembrolizumab And Stereotactic Radiosurgery (Srs) Of Selected Brain Metastases In Breast Cancer Patients
- NCT03900793 · 41 participants · Phase 1
Losartan + Sunitinib in Treatment of Osteosarcoma
- NCT04082520 · 41 participants · Phase 2
Lutathera for the Treatment of Inoperable, Progressive Meningioma After External Beam Radiation Therapy
- NCT04220190 · 41 participants · Phase 2
RAPA-501 Therapy for ALS
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia